Puma Biotechnology Inc. sell agenda2020
Start price
31.07.14
/
50%
€168.66
Target price
28.08.14
€100.00
Performance (%)
16.12%
End price
28.08.14
€195.84
Summary
This prediction ended on 28.08.14 with a price of €195.84. The SELL prediction by agenda2020 finished with a performance of 16.12%. agenda2020 has 50% into this predictionPuma Biotechnology is a publicly traded biopharmaceutical company that develops innovative cancer therapies targeting the most aggressive and difficult-to-treat forms of the disease. Puma's lead product is Nerlynx, an oral medication approved for the treatment of HER2-positive breast cancer, and the company also has a number of other promising drugs in its pipeline. Founded in 2010, Puma is headquartered in Los Angeles, California, and its shares trade on the NASDAQ exchange under the ticker symbol PBYI.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Puma Biotechnology Inc. | 22.230% | 22.230% | 10.876% | -51.658% |
| iShares Core DAX® | 0.559% | 3.148% | 14.852% | 16.725% |
| iShares Nasdaq 100 | -0.854% | 1.869% | 35.463% | 51.117% |
| iShares Nikkei 225® | 1.291% | 4.293% | 14.965% | 10.659% |
| iShares S&P 500 | 0.492% | 1.945% | 30.310% | 45.443% |
Comments by agenda2020 for this prediction
In the thread Puma Biotechnology Inc. diskutieren
wo ist der wahre wert?
+300% an einem tag! wer nimmt da nicht gewinne mit? ein hedgefond mit 1mrd gewinn in 24std, wird sich die gewinne nicht entgehen lassen!
von 59$ auf 241$! gewinnmitnahmen bis 190$! jetzt erneuter anstieg!
(Vom Mitglied beendet)
Stopped prediction by agenda2020 for Puma Biotechnology Inc.
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€168.65
30.07.14
30.07.14
€100.00
31.07.14
31.07.14
-
31.07.14
31.07.14
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€160.00
24.07.14
24.07.14
€100.00
28.07.14
28.07.14
-
28.07.14
28.07.14
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€170.60
24.07.14
24.07.14
€100.00
24.07.14
24.07.14
-6.21%
24.07.14
24.07.14